Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

Volume: 371, Issue: 23, Pages: 2155 - 2166
Published: Dec 4, 2014
Abstract
Dual antiplatelet therapy is recommended after coronary stenting to prevent thrombotic complications, yet the benefits and risks of treatment beyond 1 year are uncertain.Patients were enrolled after they had undergone a coronary stent procedure in which a drug-eluting stent was placed. After 12 months of treatment with a thienopyridine drug (clopidogrel or prasugrel) and aspirin, patients were randomly assigned to continue receiving...
Paper Details
Title
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
Published Date
Dec 4, 2014
Volume
371
Issue
23
Pages
2155 - 2166
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.